Global Information
회사소개 | 문의 | 비교리스트

세계의 바이오액티브 창상 관리 시장

Bioactive Wound Management

리서치사 Global Industry Analysts, Inc.
발행일 2022년 01월 상품 코드 997616
페이지 정보 영문 282 Pages
가격
US $ 4,950 ₩ 5,962,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 17,886,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 바이오액티브 창상 관리 시장 Bioactive Wound Management
발행일 : 2022년 01월 페이지 정보 : 영문 282 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 바이오액티브 창상 관리 시장 규모는 분석기간(2020-2027년)에 11.2%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 13억 달러에서 2027년에는 28억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 이종 이식은 분석기간 중 11.7%의 CAGR을 나타내고, 5억 5,430만 달러에 달할 전망입니다.

세계의 바이오액티브 창상 관리(Bioactive Wound Management) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • 3M Company
  • Acelity LP, Inc.
  • ACell Inc.
  • Convatec Group PLC
  • Covalon Technologies Ltd.
  • Integra LifeSciences Holdings Corporation
  • MiMedx Group, Inc.
  • Smith & Nephew PLC
  • SYMATESE
  • Wright Medical Group NV

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 세계 시장 궤적
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 44개사
LSH 21.04.09

Global Bioactive Wound Management Market to Reach US$2.5 Billion by the Year 2026

Bioactive dressings refer to dressings made using natural resources that find application in managing both chronic and acute wounds. They contain bioactive substances that remain active during the process of wound healing. The global bioactive wound management market is growing led by factors including an ageing population, growing prevalence of tissue disorders, and escalating cases of chronic wounds. The growing prevalence of lifestyle associated disorders, especially diabetes is giving rise to diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The number of people (adults aged between 20-79 years) with diabetes is expected to grow from about 463 million in 2019 to reach 700 million by 2045. These numbers also indicate the ratio of those suffering from Type II diabetes to increase in most countries. Overall, these growing cases represent opportunities and undeterred growth for global bioactive wound care management market in the coming years. At the same time, skin injuries and wound infection are also key factors driving demand for bioactive wound care management. Meanwhile, wound infection is one of the key concerns for both healthcare providers and patients across the world, and the need for effective care and management for lowering infection makes way for bioactive wound care management solutions. The market already offers technologically advanced products such as occlusive dressings for skin injuries that allow a moist environment to be maintained for promoting active healing, and keratin-based products that when used together with injury dressings allow re-epithelialization of damaged skin tissue.

Amid the COVID-19 crisis, the global market for Bioactive Wound Management estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2026, growing at a CAGR of 7.8% over the analysis period. Alginates, one of the segments analyzed in the report, is projected to grow at a 6.8% CAGR to reach US$826.1 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Collagen-Based Dressings segment is readjusted to a revised 9.1% CAGR for the next 7-year period. This segment currently accounts for a 23.9% share of the global Bioactive Wound Management market. Alginate dressing is made using highly absorbent materials to promote wound healing. This dressing finds use in exudant wounds where excess fluid is present. A key trend in the advanced wound care market is the emergence of combination dressings which are prepared using various available products of wound dressings in several different combinations, most generally including a biological agent and an antimicrobial material. Collagen and foam dressings, collagen hydrocolloid dressings, silver collagen dressings, and silver alginate dressings are some of the combination dressings that are being used for the treatment of chronic wounds.

The U.S. Market is Estimated at $650.9 Million in 2021, While China is Forecast to Reach $211.3 Million by 2026

The Bioactive Wound Management market in the U.S. is estimated at US$650.9 Million in the year 2021. The country currently accounts for a 38.66% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$211.3 Million in the year 2026 trailing a CAGR of 9.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR while Rest of European market (as defined in the study) will reach US$220.8 Million by the end of the analysis period. North America has emerged as a leading global market for advanced wound care management technologies such as bioactive wound care dressings. The regional market benefits from a rapidly expanding base of ageing population, a sizeable diabetic population, and higher prevalence of chronic diseases. The Asia-Pacific market for bioactive wound management is fast growing owing to an expanding diabetic population, with increased incidence of infections, pressure ulcers and diabetic foot among others.

Antimicrobial Dressings Segment to Reach $434 Million by 2026

Antimicrobial dressings are wound dressings that include an antiseptic agent that helps destroy microorganisms present in the wound. These dressings are mainly used for wounds that fail to heal due to increasing bacterial load, and for wounds that have a high risk of infection. Rise in demand for these dressings is also due to the growing need to reduce hospital acquired infections, and rising prevalence of bacteria which is resistant to antibiotics. In the global Antimicrobial Dressings segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$248.1 Million in the year 2020 will reach a projected size of US$377.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$27.8 Million by the year 2026.

Select Competitors (Total 90 Featured) -

  • 3M Company
  • Acelity LP, Inc.
  • Acell Inc.
  • Convatec Group PLC
  • Covalon Technologies Ltd.
  • Integra LifeSciences Holdings Corporation
  • MiMedx Group, Inc.
  • Smith & Nephew PLC
  • SYMATESE
  • Wright Medical Group NV

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Review of the World Economy in 2021
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19-Led Wound Management Crisis & Patient Suffering Create Need for Effective Interventions
    • Dwindling Revenues for Wound Care Practices
    • Telemedicine, Remote Patient Monitoring Takes Center Stage
    • Wounds & Wound Management: An Insight
    • Bioactive Wound Management: A Prelude
    • Outlook
    • Healthcare Burden of Chronic Wounds and the Need for Effective Wound Management Products
    • Prevalence and Incidence of Wounds - Select Statistics
    • EXHIBIT 2: Global Prevalence of Wounds by Type (in Millions)
    • EXHIBIT 3: Global Wound Care Market: Percentage Breakdown of Spending by Wound Type
    • EXHIBIT 4: Healing Time by Type of Wound (in Days)
    • Chronic Wounds: Select Statistics
    • Reduced Economic Cost of Wound Care Triggers Transition to Advanced Products
    • EXHIBIT 5: Breakdown of Costs Associated with Wound Care
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Effective Burn Wound Management with Bioactive Dressings
    • Uptrend in Surgical Care Augurs Well for Market Growth
    • EXHIBIT 6: Global Surgical Procedure Volume by Procedure Type
    • Rise in Prevalence of Pressure Ulcers and the Growing Focus on Treatment Solutions
    • EXHIBIT 7: Pressure Ulcer Occurrence Rate Based on the Length of Surgery
    • Understanding the Wound: A Widening Area of Interest
    • Smart" Dressings Set the Road to Futuristic Wound Care
    • Startups Enter the Fray
    • Growing Focus on Reducing Hospital Stays Lends Traction
    • Technological Advancements Remain Buoyant
    • Conductive Bio-material Wound Dressings Beneficial for Wound Healing
    • Combination Dressings Emerge as a Key Trend
    • Cellulose-based Dressings Exude Immense Potential for Chronic Wound Management
    • 3D-Printed Stem Cells & Lasers to Kill Bacteria
    • New Bioactive Wound Dressings
    • Chitin, Chitosan and Derivatives
    • Bioactive Glasses Show Promising Wound Healing Outcomes
    • Rising Incidence of Diabetes and DFUs to Propel Market Growth
    • EXHIBIT 8: World Diabetes and Population Statistics (2019, 2030 & 2045)
    • EXHIBIT 9: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • EXHIBIT 10: World Diabetes Prevalence (2000 - 2019)
    • COVID-19 Crisis & Restrictions Upend Care for Diabetic Foot Disease Patients
    • Growing Acceptance of Moist Wound Environment Spurs Demand for Moist Wound Dressings
    • Alginate Dressings Dominate the Market
    • Antimicrobial Dressings Find Application for Healing Wounds with High Bacterial Load
    • Multi-Drug Resistant Bacteria: A Pressing Concern
    • Tissue Engineering in Wound Care
    • Bioengineered Skin Substitutes
    • Collagen Dressings in Advanced Wound Care
    • Macro Growth Drivers
    • Impact of Healthcare Expenditure on Market Growth
    • EXHIBIT 11: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • EXHIBIT 12: Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050
    • Expanding Aging Population Spurs Demand
    • EXHIBIT 13: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Obesity Levels Fuel Demand
    • EXHIBIT 14: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Bioactive Wound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Bioactive Wound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 3: World 11-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2016, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Alginates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Alginates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 6: World 11-Year Perspective for Alginates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Collagen-Based Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Collagen-Based Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 9: World 11-Year Perspective for Collagen-Based Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Antimicrobial Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Antimicrobial Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 12: World 11-Year Perspective for Antimicrobial Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Bioengineered Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Bioengineered Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 15: World 11-Year Perspective for Bioengineered Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for Hydrocolloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Hydrocolloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 18: World 11-Year Perspective for Hydrocolloids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Burn Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Burn Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 21: World 11-Year Perspective for Burn Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Surgical Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Surgical Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 24: World 11-Year Perspective for Surgical Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 25: World Current & Future Analysis for Diabetic Foot Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Diabetic Foot Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 27: World 11-Year Perspective for Diabetic Foot Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 28: World Current & Future Analysis for Venous Leg Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Venous Leg Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 30: World 11-Year Perspective for Venous Leg Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 31: World Current & Future Analysis for Pressure Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Pressure Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 33: World 11-Year Perspective for Pressure Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 34: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 36: World 11-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 37: World Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 38: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 39: World 11-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027
    • TABLE 40: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 41: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 42: World 11-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 43: USA Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: USA Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 45: USA 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 46: USA Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: USA Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 48: USA 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 49: USA Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: USA Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 51: USA 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • CANADA
    • TABLE 52: Canada Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Canada Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 54: Canada 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 55: Canada Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Canada Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 57: Canada 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 58: Canada Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Canada Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 60: Canada 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • JAPAN
    • TABLE 61: Japan Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Japan Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 63: Japan 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 64: Japan Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Japan Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 66: Japan 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 67: Japan Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Japan Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 69: Japan 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • CHINA
    • TABLE 70: China Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: China Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 72: China 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 73: China Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: China Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 75: China 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 76: China Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: China Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 78: China 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • EUROPE
    • TABLE 79: Europe Current & Future Analysis for Bioactive Wound Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for Bioactive Wound Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 81: Europe 11-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2016, 2021 & 2027
    • TABLE 82: Europe Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Europe Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 84: Europe 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 85: Europe Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Europe Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 87: Europe 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 88: Europe Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Europe Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 90: Europe 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • FRANCE
    • TABLE 91: France Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: France Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 93: France 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 94: France Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: France Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 96: France 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 97: France Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: France Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 99: France 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • GERMANY
    • TABLE 100: Germany Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Germany Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 102: Germany 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 103: Germany Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Germany Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 105: Germany 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 106: Germany Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Germany Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 108: Germany 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • ITALY
    • TABLE 109: Italy Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Italy Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 111: Italy 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 112: Italy Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Italy Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 114: Italy 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 115: Italy Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Italy Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 117: Italy 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 118: UK Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: UK Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 120: UK 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 121: UK Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: UK Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 123: UK 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 124: UK Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: UK Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 126: UK 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • REST OF EUROPE
    • TABLE 127: Rest of Europe Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Europe Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 129: Rest of Europe 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 130: Rest of Europe Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 136: Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Asia-Pacific Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 138: Asia-Pacific 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 139: Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027
  • REST OF WORLD
    • TABLE 145: Rest of World Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Rest of World Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 147: Rest of World 11-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2021 & 2027
    • TABLE 148: Rest of World Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Rest of World Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 150: Rest of World 11-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027
    • TABLE 151: Rest of World Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Rest of World Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
    • TABLE 153: Rest of World 11-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 90
Back to Top
전화 문의
F A Q